Atovaquone | Interleukin Related interleukin-related.com

Product Name :
Atovaquone

Search keywords :
Cytochrome C

drugId :
null

Target Vo:
Cytochrome b

Target Vo Short Name :
Cytochrome b

Moa_Name:
Cytochrome b inhibitors

First Approval Country :
United States

First Approval Date Filter:
1992

Origin Company_Name :
Glaxosmithkline Plc

Active Company_Name :
Emory University

Active Indication_Name:
Cystadenocarcinoma, Serous

In Active Indication_Name:
HIV Infections

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
SIRT2 Antibody
Wnt5b Antibody (YA653)
RFP Tag Antibody (YA882): RFP Tag Antibody (YA882) is an unconjugated, mouse-derived, anti-RFP Tag (YA882) monoclonal antibody. RFP Tag Antibody (YA882) can be used for: WB expriments in species-independent background without labeling.

Author: Interleukin Related

Related Posts